Skip to Content
Merck
CN

258083

4-Bromobutyric acid

98%

Synonym(s):

4-Bromobutanoic acid

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Linear Formula:
Br(CH2)3COOH
CAS Number:
2623-87-2
Molecular Weight:
167.00
UNSPSC Code:
12352106
NACRES:
NA.22
PubChem Substance ID:
24855626
EC Number:
220-083-9
Beilstein/REAXYS Number:
1743056
MDL number:
MFCD00002817

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

4-Bromobutyric acid, 98%

InChI key

GRHQDJDRGZFIPO-UHFFFAOYSA-N

InChI

1S/C4H7BrO2/c5-3-1-2-4(6)7/h1-3H2,(H,6,7)

SMILES string

BrCCCC(O)=O

assay

98%

form

solid

reaction suitability

reagent type: cross-linking reagent

bp

128-131 °C/11 mmHg (lit.)

mp

30-31 °C (lit.)

functional group

bromo
carboxylic acid

Quality Level

100

Looking for similar products? Visit Product Comparison Guide

Related Categories

pictograms

Corrosion
GHS05

signalword

Danger

hcodes

H314

Hazard Classifications

Skin Corr. 1B

Storage Class

8A - Combustible corrosive hazardous materials

wgk

WGK 3

flash_point_f

230.0 °F - closed cup

flash_point_c

110 °C - closed cup

ppe

Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
WXBF7741V
WXBF1415V
WXBD4504V
STBJ8586
STBJ8842

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

E Montanari et al.
Journal of controlled release : official journal of the Controlled Release Society, 326, 1-12 (2020-06-20)
Intracellular pathogens are a critical challenge for antimicrobial therapies. Staphylococcus aureus (S. aureus) causes approximately 85% of all skin and soft tissue infections in humans worldwide and more than 30% of patients develop chronic or recurrent infections within three months
E Montanari et al.
Carbohydrate polymers, 221, 209-220 (2019-06-23)
Hyaluronan (HA) is among the most used biopolymers for viscosupplementation and dermocosmetics. However, the current injectable HA-based formulations present relevant limitations: I) unmodified HA is quickly degraded by endogenous hyaluronidases (HAase), resulting in short lasting properties; II) cross-linked HA, although
Elita Montanari et al.
Advanced healthcare materials, 7(12), e1701483-e1701483 (2018-04-27)
Staphylococcus aureus is one of the most significant human pathogens that is frequently isolated in a wide range of superficial and systemic infections. The ability of S. aureus to invade and survive within host cells such as keratinocytes and host
Amelia C McCue et al.
Photochemistry and photobiology, 94(3), 545-551 (2018-01-30)
Light-responsive compounds have been used to manipulate biological systems with spatial and temporal control of the event of interest. Illumination of alkylcobalamins with green light (>500 nm) produces carbon-centered radicals, which have been demonstrated to effectively cause DNA damage. Molecules that
Renwu Li et al.
Bioorganic & medicinal chemistry, 28(7), 115356-115356 (2020-02-19)
Past few years have seen an active pursuit of the inhibitors for the deacylation catalyzed by the seven human sirtuins (i.e. SIRT1-7) as valuable chemical biological/pharmacological probes of this enzymatic deacylation and lead compounds for developing novel therapeutics for human
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service